ScholarIQanswers from OpenAlex & ORCID
Hidetaka Uramoto
ResearcherPublications, citations & collaboration network
Hidetaka Uramoto is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Hidetaka Uramoto have?
ScholarIQindexed works
Hidetaka Uramoto has 491 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hidetaka Uramoto have?
ScholarIQcitation count
Hidetaka Uramoto has 8,887 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Hidetaka Uramoto?
ScholarIQh-index
Hidetaka Uramoto has an h-index of 44 in OpenAlex.
What is the i10-index of Hidetaka Uramoto?
ScholarIQi10-index
Hidetaka Uramoto has an i10-index of 187 in OpenAlex.
What is the ORCID of Hidetaka Uramoto?
ScholarIQorcid
The ORCID for Hidetaka Uramoto is on the source record.
What is the OpenAlex record for Hidetaka Uramoto?
ScholarIQopenalex
The OpenAlex for Hidetaka Uramoto is on the source record.
What are the most-cited papers on Hidetaka Uramoto?
ScholarIQmost cited works
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Hidetaka Uramoto, Yoichiro Yoshida, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Takeshi Yoshida, Minoru Nomoto, Kimitoshi Kohno
Recurrence after surgery in patients with NSCLC.
Hidetaka Uramoto, Fumihiro Tanaka
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang, Michael Hölzel, Theo Knijnenburg, Andreas Schlicker, Paul Roepman, Ultan McDermott, Mathew J. Garnett, Wipawadee Grernrum, Chong Sun, Anirudh Prahallad, Floris H. Groenendijk, Lorenza Mittempergher, Wouter Nijkamp, Jacques Neefjes, Ramón Salazar, Peter ten Dijke, Hidetaka Uramoto, Fumihiro Tanaka, Roderick L. Beijersbergen, Lodewyk F.A. Wessels, René Bernards
Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
Seiji Yano, Tadaaki Yamada, Shinji Takeuchi, Keisei Tachibana, Yuko Minami, Yasushi Yatabe, Tetsuya Mitsudomi, Hidenori Tanaka, Tatsuo Kimura, Shinzoh Kudoh, Hiroshi Nokihara, Yuichiro Ohe, Jun Yokota, Hidetaka Uramoto, Kosei Yasumoto, Katsuyuki Kiura, Masahiko Higashiyama, Makoto Oda, Haruhiro Saito, Junji Yoshida, Kazuya Kondoh, Masayuki Noguchi
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Hiroto Izumi, Mayu Takahashi, Hidetaka Uramoto, Yoshifumi Nakayama, Tsunehiro Oyama, Ke‐Yong Wang, Yasuyuki Sasaguri, Shigeru Nishizawa, Kimitoshi Kohno